LMC|Manna Research is the largest network of fully-owned and integrated clinical research sites in Canada providing Phase I-IV clinical trial services. With specialized focus on endocrine disorders, RWE – Big Data, vaccine research, and primary care studies.
LMC|Manna Research provides Sponsors, CRO’s & ARO’s access to one of the largest fully owned and operated clinical research site networks within Canada at 18 sites across 4 provinces.
LMC Diabetes primary focus is diabetes, obesity, metabolic and cardiovascular disease. Manna Research is a combination of diseases, but focuses 30% of their efforts in diabetes and metabolic diseases.
Principle Investigators at each site follow a uniform set of SOPs, conforming to ICH, GCP, and Health Canada Division 5 guidelines. Internal training, fellowship, and certification are all provided.
LMC|Manna Research is the proud winner of the 2017 Site Patient Recruitment Innovation Award (SPRIA), which recognizes sites that employ innovative strategies to achieve enrollment success.
Participants to Date
Improving the health of Canadians today and tomorrow through clinical research.
PASSIONATE & INNOVATIVE LEADERS
PURSUIT OF EXCELLENCE
Learn More About LMC | Manna Research
Feel free to reach out to us to discuss partnerships or to learn more about LMC | Manna Research.